SlideShare una empresa de Scribd logo
1 de 37
Lecture prepared by
Mark Randa; Ph.D.
Vaccines
History of Vaccines
 Variolation: Inoculation of smallpox into skin
(18th century). Mortality rate of 1% for variolation; 50%
mortality rate from smallpox.
 Vaccine: a suspension of organisms or fractions of
organisms that is used to induced immunity
 Vaccination:
- Inoculation of cowpox virus into skin (Jenner)
- Inoculation with rabies virus (Pasteur)
 Herd Immunity
What is a Vaccine ?
 A vaccine is the deliberate stimulation of adaptive immunity.
- Work by mimicking what happens during natural infection
without causing illness.
- Use altered versions of viruses or bacteria to trigger an
immune response.
- Are the most effective means of controlling infectious
diseases.
- Not only protect those who get them, but they also help
keep diseases at bay in the community; this is called herd
immunity
How Do Vaccines Work?
 During natural infection:
- The immune system recognizes a pathogen as foreign and
makes an immune response to it. When a pathogen causes an
immune response, it is known as an antigen.
- Unfortunately, while the immune response is gaining strength,
the person is likely to be ill as the struggle between the pathogen
and the immune response is decided.
- One part of the immune response creates antibodies; this is
known as the antibody-mediated or humoral immune response.
- Antibodies are specific to antigens and have the ability to
remember them, so that if the same (or a very similar) antigen
tries to infect the person again, the immune response will be
stronger and faster thereby protecting the person from infection
—and illness.
How Do Vaccines Work ?
 With a vaccine:
- The immune system recognizes the vaccine as foreign and
makes an immune response to it. The vaccine serves as an
antigen in that it causes the immune system to respond to it.
- One part of the immune response creates antibodies; this is
known as the antibody-mediated or humoral immune response.
- Antibodies are specific to the vaccine and have the ability to
remember it, so that if the vaccine or a very similar antigen is
seen again, the immune response will be stronger and faster
thereby protecting the person from infection.
- The main difference between a vaccine and natural infection is
that the person does not become ill while the immune system is
responding to the vaccine.
Vaccines changed medicine
 Vaccines have literally transformed the landscape of
medicine over the course of the 20th century. Before
vaccines, parents in the United States could expect that every
year:
- Polio would paralyze 10,000 children.
- Rubella (German measles) would cause birth defects and
mental retardation in as many as 20,000 newborns.
- Measles would infect about 4 million children, killing 3,000.
- Diphtheria would be one of the most common causes of death
in school-aged children.
- A bacterium called Haemophilus influenzae type b (Hib) would
cause meningitis in 15,000 children, leaving many with
permanent brain damage.
- Pertussis (whooping cough) would kill thousands of infants.
Prevalence of polio (blue), measles (red), mumps (green),
and rubella (purple) in the US from 1950-2009, the black
lines indicate the introduction of a vaccine to protect
against each disease
Vaccine
Vaccine
Vaccine
Types of Vaccines
1. Attenuated whole-agent vaccines
 Living but weakened microbes.
 Living microbes more closely mimic an actual infection.
 Lifelong immunity is often achieved without booster
immunizations (effectiveness rate of 95% is not unusual).
 Long term effectiveness probably occurs because the
attenuated microbe replicates in the body, increasing the
original dose and acting as a secondary (booster)
immunization.
 Example: MMR (measles mumps and rubella) and TB
 Risk: Weakened microbes can back-mutate to virulent
form
Types of Vaccines
2. Inactivated whole-agent vaccines
 Use microbes that have been killed, usually by formalin or
phenol.
 Examples of viruses: rabies, influenza, and Salk polio.
 Examples of bacteria: pneumococcal pneumonia and
cholera.
3. Toxoids
 Inactivated toxins
 Tetanus and diphtheria
Types of Vaccines
4. Subunit vaccines
 Use only antigenic fragments of a microorganism that
best stimulates the immune response.
 Acellular: a vaccine consisting of antigenic parts
(example- pertussis)
 Recombinant: uses recombinant DNA technology;
another microbes are programed to produce the
antigenic parts (example-hepatitis B).
Types of Vaccines
5. Conjugated Vaccine:
 A vaccine consisting of the desired antigen and other
proteins.
 Deals with poor immune response of children to vaccines
based on capsular polysaccharides (children typical to
respond to these antigens until 18-24 months).
 Polysaccharides are combined with proteins (diptheria
toxoid) which gives significant protection (2 months).
 Example: Haemophilus influenza type b
Types of Vaccines
6. Nucleic acid (DNA) vaccines
 Plasmid DNA injected into muscle results in the production
of the protein antigen encoded on the DNA
 Example: West Nile (for horses)
 Clinical trials underway in humans
 Many advantages for the less developed countries- gene
gun eliminate needles and syringes, requires no
refrigeration, and lower cost.
ANIMATION Vaccines: Types
Vaccines Used to Prevent Bacterial
Diseases
Disease Vaccine
Diphtheria Purified diphtheria toxoid
Meningococcal meningitis
Purified polysaccharide from
Neisseria meningitidis
Pertussis (whooping
cough)
Killed whole or acellular fragments of
Bordetella pertussis
Pneumococcal
pneumonia
Purified polysaccharide from 7
strains of Streptococcus pneumoniae
Tetanus Purified tetanus toxoid
Haemophilus influenza
type b meningitis
Polysaccharide from Haemophilus
influenzae type b conjugated with
protein to enhance effectiveness
Disease Vaccine
Influenza
Injected vaccine, inactivated virus
(nasally administered: attenuated
virus)
Measles Attenuated virus
Mumps Attenuated virus
Rubella Attenuated virus
Chickenpox Attenuated virus
Poliomyelitis Killed virus
Vaccines Used to Prevent Bacterial
Diseases
Disease Vaccine
Rabies Killed virus
Hepatitis B Antigenic fragments of virus
Hepatitis A Inactivated virus
Smallpox Live vaccinia virus
Herpes zoster Attenuated virus
Human papillomavirus Antigenic fragments of virus
Vaccines Used to Prevent Bacterial
Diseases
Adults
 Most adults don’t realize there are times when they, too,
need vaccines:
 At certain ages
 During pregnancy
 Before travel
 For occupational risks
 When they have certain medical conditions
Vaccines for Adults
• Td/Tdap
• Human Papillomavirus (HPV)
• Varicella
• Herpes Zoster
• Measles, Mumps and Rubella
• Influenza
• Pneumococcal
• Hepatitis A
• Hepatitis B
• Meningococcus
Lecture prepared by
Mark Randa; Ph.D.
Herd Immunity
No one vaccinated…
Some of the population
vaccinated…
Most of the population vaccinated…
R0: basic reproduction number; this number represents how many people in an
unprotected population one infected person could pass the disease along to
Lecture prepared by
Mark Randa; Ph.D.
Watch the Following Video (HAS PROFANITY)
Penn & Teller's Bullshit – Vaccinations
https://www.youtube.com/watch?v=lhk7-5eBCrs
Anti-Vaccine Movement
The cause of the anti-vaccine
movement…
 Many anti-vaccine parents mistakenly think that the scientific jury is out
 In reality, there are no lingering questions, and it is important to recognize
that deviousness was involved in the mere suggestion of a link.
 Not only was there never any evidence to support the notion that the
vaccination caused autism, the research that supposedly supported this
link was in fact wholly fabricated.
 Unfortunately, the facts of this fraud get forgotten.
 Discussions occasionally mention that the research has been
"discredited," but that description is in fact a massive understatement
The journal article…
 In 1998, a British surgeon, Dr. Andrew Wakefield, published a
paper in The Lancet with 12 co-authors, reporting that the
measles, mumps and rubella (MMR) vaccine was associated with
"regressive autism" and colitis in 12 children.
 The paper ignited and propelled anti-vaccine campaigns
throughout the world.
 A journalist, Brian Deer, began investigating these children's
medical records and found that the paper's data were largely
fabricated.
The truth about the children…
 Of the 11 children reported as having colitis, only 3 did, according to
the medical records.
 Wakefield claimed that all 12 children were "previously normal," while
in fact 5 had developmental problems before receiving the vaccine.
 Of the 9 with regressive autism, 3 had no autism at all.
 Of the 8 children who reportedly developed symptoms only days after
receiving the vaccine -- which would be important in convincing a
court that the vaccine was to blame -- 6 took much longer, and for 2
it is not clear.
 While Wakefield claimed 6 of the 12 children had all three features --
autism, colitis, and development of symptoms days after the
vaccination, in fact, 0 did.
And it gets worse…
 It turns out that in 1994, a British-based anti-vaccine group,
JABS, claimed that the MMR vaccine causes brain damage
and other problems, and hired a lawyer, Richard Barr, who
then retained Wakefield, a surgeon.
 Barr began sending Wakefield patients from the group, and
paid Wakefield over $700,000.
 Most of the children's parents were associated with the anti-
vaccine group -- hardly an unbiased group.
What happened…
 After Deer's investigation, Wakefield at first claimed
innocence, saying that the other authors had written the
final paper. In fact, he had written the paper, and the other
authors had signed on.
 The General Medical Council began an investigation,
lasting 217 days, and concluded that Wakefield had
falsified the research.
 The Lancet later retracted the paper, but only 12 years
after publishing it.
Where is he now…
 Wakefield's medical ambitions having been stifled, he is now
appearing as a speaker at conspiracy crank events, as well as
being the patron saint of anti-vaxxers everywhere.
 In January 2012, Wakefield filed a defamation suit against Brian
Deer, the British Medical Journal and the BMJ's editor Fiona
Godlee personally.
 The BMJ Group has noted that they stand by their article (and
pointedly call him "Mr. Wakefield" throughout the press release to
this effect). This suit was dismissed on jurisdictional grounds.

Más contenido relacionado

La actualidad más candente

Parasite Vaccines in Trials and in Use
Parasite Vaccines in Trials and in UseParasite Vaccines in Trials and in Use
Parasite Vaccines in Trials and in Usedranjansarma
 
Vaccination history
Vaccination historyVaccination history
Vaccination historyJohn Bergman
 
Innovations in Vaccinology
Innovations in VaccinologyInnovations in Vaccinology
Innovations in VaccinologyPamoja
 
Vaccine as immunotheraputic agent
Vaccine as immunotheraputic agent Vaccine as immunotheraputic agent
Vaccine as immunotheraputic agent Ahmed Hamza
 
Investigate the vaccine for malaria
Investigate the vaccine for malaria  Investigate the vaccine for malaria
Investigate the vaccine for malaria Xplore Health
 
Global Medical Cures™ | Understanding VACCINES
Global Medical Cures™ | Understanding VACCINESGlobal Medical Cures™ | Understanding VACCINES
Global Medical Cures™ | Understanding VACCINESGlobal Medical Cures™
 
Basic concept of vaccination
Basic concept of vaccinationBasic concept of vaccination
Basic concept of vaccinationSam Kyley
 
Viral vaccine & it’s effect awkum
Viral vaccine & it’s effect awkumViral vaccine & it’s effect awkum
Viral vaccine & it’s effect awkumWaleed Qadar
 
Priya early childhood immunization programs
Priya early childhood immunization programsPriya early childhood immunization programs
Priya early childhood immunization programsrsbkh
 

La actualidad más candente (18)

Vaccinology
VaccinologyVaccinology
Vaccinology
 
Parasite Vaccines in Trials and in Use
Parasite Vaccines in Trials and in UseParasite Vaccines in Trials and in Use
Parasite Vaccines in Trials and in Use
 
Vaccination history
Vaccination historyVaccination history
Vaccination history
 
VACCINES
VACCINESVACCINES
VACCINES
 
Newer vaccine
Newer vaccineNewer vaccine
Newer vaccine
 
Autism Vaccine
Autism VaccineAutism Vaccine
Autism Vaccine
 
Vaccines 1
Vaccines  1Vaccines  1
Vaccines 1
 
Innovations in Vaccinology
Innovations in VaccinologyInnovations in Vaccinology
Innovations in Vaccinology
 
Vaccine
VaccineVaccine
Vaccine
 
Vaccination
VaccinationVaccination
Vaccination
 
Vaccine as immunotheraputic agent
Vaccine as immunotheraputic agent Vaccine as immunotheraputic agent
Vaccine as immunotheraputic agent
 
Investigate the vaccine for malaria
Investigate the vaccine for malaria  Investigate the vaccine for malaria
Investigate the vaccine for malaria
 
Global Medical Cures™ | Understanding VACCINES
Global Medical Cures™ | Understanding VACCINESGlobal Medical Cures™ | Understanding VACCINES
Global Medical Cures™ | Understanding VACCINES
 
Basic concept of vaccination
Basic concept of vaccinationBasic concept of vaccination
Basic concept of vaccination
 
Vaccination
VaccinationVaccination
Vaccination
 
Viral vaccine & it’s effect awkum
Viral vaccine & it’s effect awkumViral vaccine & it’s effect awkum
Viral vaccine & it’s effect awkum
 
Priya early childhood immunization programs
Priya early childhood immunization programsPriya early childhood immunization programs
Priya early childhood immunization programs
 
Vaccine and it types
Vaccine and it types Vaccine and it types
Vaccine and it types
 

Similar a Vaccinesherdimmunityantivaccinemovt 150213065803-conversion-gate01

Homoeopathic prophylaxis VS Vaccination
Homoeopathic prophylaxis VS VaccinationHomoeopathic prophylaxis VS Vaccination
Homoeopathic prophylaxis VS VaccinationAnit Singh Vikram
 
Anti vaccination movement
Anti vaccination movementAnti vaccination movement
Anti vaccination movementSakshiDave2
 
Vaccination measles
Vaccination  measles Vaccination  measles
Vaccination measles John Bergman
 
INTRODUCTION TO IMMUNIZATION
INTRODUCTION TO IMMUNIZATIONINTRODUCTION TO IMMUNIZATION
INTRODUCTION TO IMMUNIZATIONVikas Soni
 
Vaccines and their effect on public health
Vaccines and their effect on public healthVaccines and their effect on public health
Vaccines and their effect on public healthGriffin Walker
 
vaccines and anti-viral drugs
vaccines and anti-viral drugsvaccines and anti-viral drugs
vaccines and anti-viral drugsjawaria sultan
 
Nature vaccine development timeline 20 major milestones
Nature vaccine development timeline   20 major milestonesNature vaccine development timeline   20 major milestones
Nature vaccine development timeline 20 major milestonesDoriaFang
 
MMR Slide Show (Final)
MMR Slide Show (Final)MMR Slide Show (Final)
MMR Slide Show (Final)comotrekker
 
Vaccine Delivery System
Vaccine Delivery SystemVaccine Delivery System
Vaccine Delivery SystemMOHAMMAD ASIM
 

Similar a Vaccinesherdimmunityantivaccinemovt 150213065803-conversion-gate01 (15)

Homoeopathic prophylaxis VS Vaccination
Homoeopathic prophylaxis VS VaccinationHomoeopathic prophylaxis VS Vaccination
Homoeopathic prophylaxis VS Vaccination
 
Anti vaccination movement
Anti vaccination movementAnti vaccination movement
Anti vaccination movement
 
Vaccination measles
Vaccination  measles Vaccination  measles
Vaccination measles
 
Vaccine
VaccineVaccine
Vaccine
 
INTRODUCTION TO IMMUNIZATION
INTRODUCTION TO IMMUNIZATIONINTRODUCTION TO IMMUNIZATION
INTRODUCTION TO IMMUNIZATION
 
B10vrv8353
B10vrv8353B10vrv8353
B10vrv8353
 
Vaccines and their effect on public health
Vaccines and their effect on public healthVaccines and their effect on public health
Vaccines and their effect on public health
 
vaccines and anti-viral drugs
vaccines and anti-viral drugsvaccines and anti-viral drugs
vaccines and anti-viral drugs
 
Nature vaccine development timeline 20 major milestones
Nature vaccine development timeline   20 major milestonesNature vaccine development timeline   20 major milestones
Nature vaccine development timeline 20 major milestones
 
Vaccines
VaccinesVaccines
Vaccines
 
Vaccines Letter
Vaccines LetterVaccines Letter
Vaccines Letter
 
Vaccine in Nepal
Vaccine in NepalVaccine in Nepal
Vaccine in Nepal
 
FINAL CNI 322
FINAL CNI 322FINAL CNI 322
FINAL CNI 322
 
MMR Slide Show (Final)
MMR Slide Show (Final)MMR Slide Show (Final)
MMR Slide Show (Final)
 
Vaccine Delivery System
Vaccine Delivery SystemVaccine Delivery System
Vaccine Delivery System
 

Más de Cleophas Rwemera

Chapter003 150907175411-lva1-app6891
Chapter003 150907175411-lva1-app6891Chapter003 150907175411-lva1-app6891
Chapter003 150907175411-lva1-app6891Cleophas Rwemera
 
Chapter002 150831173907-lva1-app6892
Chapter002 150831173907-lva1-app6892Chapter002 150831173907-lva1-app6892
Chapter002 150831173907-lva1-app6892Cleophas Rwemera
 
Chapter001 150823230128-lva1-app6892
Chapter001 150823230128-lva1-app6892Chapter001 150823230128-lva1-app6892
Chapter001 150823230128-lva1-app6892Cleophas Rwemera
 
Chapter25 cancer-140105085413-phpapp01
Chapter25 cancer-140105085413-phpapp01Chapter25 cancer-140105085413-phpapp01
Chapter25 cancer-140105085413-phpapp01Cleophas Rwemera
 
Chapter24 immunology-140105101108-phpapp02
Chapter24 immunology-140105101108-phpapp02Chapter24 immunology-140105101108-phpapp02
Chapter24 immunology-140105101108-phpapp02Cleophas Rwemera
 
Chapter23 nervecells-140105100942-phpapp02
Chapter23 nervecells-140105100942-phpapp02Chapter23 nervecells-140105100942-phpapp02
Chapter23 nervecells-140105100942-phpapp02Cleophas Rwemera
 
Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02
Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02
Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02Cleophas Rwemera
 
Chapter21 cellbirthlineageanddeath-140105095914-phpapp02
Chapter21 cellbirthlineageanddeath-140105095914-phpapp02Chapter21 cellbirthlineageanddeath-140105095914-phpapp02
Chapter21 cellbirthlineageanddeath-140105095914-phpapp02Cleophas Rwemera
 
Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01
Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01
Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01Cleophas Rwemera
 
Chapter19 integratingcellsintotissues-140105095535-phpapp02
Chapter19 integratingcellsintotissues-140105095535-phpapp02Chapter19 integratingcellsintotissues-140105095535-phpapp02
Chapter19 integratingcellsintotissues-140105095535-phpapp02Cleophas Rwemera
 
Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...
Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...
Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...Cleophas Rwemera
 
Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02
Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02
Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02Cleophas Rwemera
 
Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...
Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...
Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...Cleophas Rwemera
 
Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...
Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...
Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...Cleophas Rwemera
 
Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01
Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01
Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01Cleophas Rwemera
 
Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01
Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01
Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01Cleophas Rwemera
 
Chapter12 cellularenergetics-140105093734-phpapp01
Chapter12 cellularenergetics-140105093734-phpapp01Chapter12 cellularenergetics-140105093734-phpapp01
Chapter12 cellularenergetics-140105093734-phpapp01Cleophas Rwemera
 
Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02
Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02
Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02Cleophas Rwemera
 
Chapter10 biomembranestructure-140105093829-phpapp02
Chapter10 biomembranestructure-140105093829-phpapp02Chapter10 biomembranestructure-140105093829-phpapp02
Chapter10 biomembranestructure-140105093829-phpapp02Cleophas Rwemera
 
Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01
Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01
Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01Cleophas Rwemera
 

Más de Cleophas Rwemera (20)

Chapter003 150907175411-lva1-app6891
Chapter003 150907175411-lva1-app6891Chapter003 150907175411-lva1-app6891
Chapter003 150907175411-lva1-app6891
 
Chapter002 150831173907-lva1-app6892
Chapter002 150831173907-lva1-app6892Chapter002 150831173907-lva1-app6892
Chapter002 150831173907-lva1-app6892
 
Chapter001 150823230128-lva1-app6892
Chapter001 150823230128-lva1-app6892Chapter001 150823230128-lva1-app6892
Chapter001 150823230128-lva1-app6892
 
Chapter25 cancer-140105085413-phpapp01
Chapter25 cancer-140105085413-phpapp01Chapter25 cancer-140105085413-phpapp01
Chapter25 cancer-140105085413-phpapp01
 
Chapter24 immunology-140105101108-phpapp02
Chapter24 immunology-140105101108-phpapp02Chapter24 immunology-140105101108-phpapp02
Chapter24 immunology-140105101108-phpapp02
 
Chapter23 nervecells-140105100942-phpapp02
Chapter23 nervecells-140105100942-phpapp02Chapter23 nervecells-140105100942-phpapp02
Chapter23 nervecells-140105100942-phpapp02
 
Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02
Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02
Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02
 
Chapter21 cellbirthlineageanddeath-140105095914-phpapp02
Chapter21 cellbirthlineageanddeath-140105095914-phpapp02Chapter21 cellbirthlineageanddeath-140105095914-phpapp02
Chapter21 cellbirthlineageanddeath-140105095914-phpapp02
 
Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01
Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01
Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01
 
Chapter19 integratingcellsintotissues-140105095535-phpapp02
Chapter19 integratingcellsintotissues-140105095535-phpapp02Chapter19 integratingcellsintotissues-140105095535-phpapp02
Chapter19 integratingcellsintotissues-140105095535-phpapp02
 
Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...
Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...
Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...
 
Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02
Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02
Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02
 
Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...
Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...
Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...
 
Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...
Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...
Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...
 
Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01
Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01
Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01
 
Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01
Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01
Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01
 
Chapter12 cellularenergetics-140105093734-phpapp01
Chapter12 cellularenergetics-140105093734-phpapp01Chapter12 cellularenergetics-140105093734-phpapp01
Chapter12 cellularenergetics-140105093734-phpapp01
 
Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02
Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02
Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02
 
Chapter10 biomembranestructure-140105093829-phpapp02
Chapter10 biomembranestructure-140105093829-phpapp02Chapter10 biomembranestructure-140105093829-phpapp02
Chapter10 biomembranestructure-140105093829-phpapp02
 
Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01
Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01
Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01
 

Último

USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...Postal Advocate Inc.
 
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSJoshuaGantuangco2
 
Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Celine George
 
How to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPHow to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPCeline George
 
ROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxVanesaIglesias10
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatYousafMalik24
 
Barangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptxBarangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptxCarlos105
 
Concurrency Control in Database Management system
Concurrency Control in Database Management systemConcurrency Control in Database Management system
Concurrency Control in Database Management systemChristalin Nelson
 
4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptxmary850239
 
Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4JOYLYNSAMANIEGO
 
Food processing presentation for bsc agriculture hons
Food processing presentation for bsc agriculture honsFood processing presentation for bsc agriculture hons
Food processing presentation for bsc agriculture honsManeerUddin
 
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONTHEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONHumphrey A Beña
 
Music 9 - 4th quarter - Vocal Music of the Romantic Period.pptx
Music 9 - 4th quarter - Vocal Music of the Romantic Period.pptxMusic 9 - 4th quarter - Vocal Music of the Romantic Period.pptx
Music 9 - 4th quarter - Vocal Music of the Romantic Period.pptxleah joy valeriano
 
ICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfVanessa Camilleri
 
Integumentary System SMP B. Pharm Sem I.ppt
Integumentary System SMP B. Pharm Sem I.pptIntegumentary System SMP B. Pharm Sem I.ppt
Integumentary System SMP B. Pharm Sem I.pptshraddhaparab530
 
Activity 2-unit 2-update 2024. English translation
Activity 2-unit 2-update 2024. English translationActivity 2-unit 2-update 2024. English translation
Activity 2-unit 2-update 2024. English translationRosabel UA
 
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITYISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITYKayeClaireEstoconing
 

Último (20)

USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
 
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
 
Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17
 
How to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPHow to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERP
 
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptxFINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
 
ROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptx
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice great
 
Barangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptxBarangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptx
 
Concurrency Control in Database Management system
Concurrency Control in Database Management systemConcurrency Control in Database Management system
Concurrency Control in Database Management system
 
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptxLEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
 
4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx
 
Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4
 
Food processing presentation for bsc agriculture hons
Food processing presentation for bsc agriculture honsFood processing presentation for bsc agriculture hons
Food processing presentation for bsc agriculture hons
 
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONTHEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
 
Music 9 - 4th quarter - Vocal Music of the Romantic Period.pptx
Music 9 - 4th quarter - Vocal Music of the Romantic Period.pptxMusic 9 - 4th quarter - Vocal Music of the Romantic Period.pptx
Music 9 - 4th quarter - Vocal Music of the Romantic Period.pptx
 
ICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdf
 
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptxYOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
 
Integumentary System SMP B. Pharm Sem I.ppt
Integumentary System SMP B. Pharm Sem I.pptIntegumentary System SMP B. Pharm Sem I.ppt
Integumentary System SMP B. Pharm Sem I.ppt
 
Activity 2-unit 2-update 2024. English translation
Activity 2-unit 2-update 2024. English translationActivity 2-unit 2-update 2024. English translation
Activity 2-unit 2-update 2024. English translation
 
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITYISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
 

Vaccinesherdimmunityantivaccinemovt 150213065803-conversion-gate01

  • 1. Lecture prepared by Mark Randa; Ph.D. Vaccines
  • 2. History of Vaccines  Variolation: Inoculation of smallpox into skin (18th century). Mortality rate of 1% for variolation; 50% mortality rate from smallpox.  Vaccine: a suspension of organisms or fractions of organisms that is used to induced immunity  Vaccination: - Inoculation of cowpox virus into skin (Jenner) - Inoculation with rabies virus (Pasteur)  Herd Immunity
  • 3. What is a Vaccine ?  A vaccine is the deliberate stimulation of adaptive immunity. - Work by mimicking what happens during natural infection without causing illness. - Use altered versions of viruses or bacteria to trigger an immune response. - Are the most effective means of controlling infectious diseases. - Not only protect those who get them, but they also help keep diseases at bay in the community; this is called herd immunity
  • 4. How Do Vaccines Work?  During natural infection: - The immune system recognizes a pathogen as foreign and makes an immune response to it. When a pathogen causes an immune response, it is known as an antigen. - Unfortunately, while the immune response is gaining strength, the person is likely to be ill as the struggle between the pathogen and the immune response is decided. - One part of the immune response creates antibodies; this is known as the antibody-mediated or humoral immune response. - Antibodies are specific to antigens and have the ability to remember them, so that if the same (or a very similar) antigen tries to infect the person again, the immune response will be stronger and faster thereby protecting the person from infection —and illness.
  • 5. How Do Vaccines Work ?  With a vaccine: - The immune system recognizes the vaccine as foreign and makes an immune response to it. The vaccine serves as an antigen in that it causes the immune system to respond to it. - One part of the immune response creates antibodies; this is known as the antibody-mediated or humoral immune response. - Antibodies are specific to the vaccine and have the ability to remember it, so that if the vaccine or a very similar antigen is seen again, the immune response will be stronger and faster thereby protecting the person from infection. - The main difference between a vaccine and natural infection is that the person does not become ill while the immune system is responding to the vaccine.
  • 6. Vaccines changed medicine  Vaccines have literally transformed the landscape of medicine over the course of the 20th century. Before vaccines, parents in the United States could expect that every year: - Polio would paralyze 10,000 children. - Rubella (German measles) would cause birth defects and mental retardation in as many as 20,000 newborns. - Measles would infect about 4 million children, killing 3,000. - Diphtheria would be one of the most common causes of death in school-aged children. - A bacterium called Haemophilus influenzae type b (Hib) would cause meningitis in 15,000 children, leaving many with permanent brain damage. - Pertussis (whooping cough) would kill thousands of infants.
  • 7. Prevalence of polio (blue), measles (red), mumps (green), and rubella (purple) in the US from 1950-2009, the black lines indicate the introduction of a vaccine to protect against each disease Vaccine Vaccine Vaccine
  • 8.
  • 9. Types of Vaccines 1. Attenuated whole-agent vaccines  Living but weakened microbes.  Living microbes more closely mimic an actual infection.  Lifelong immunity is often achieved without booster immunizations (effectiveness rate of 95% is not unusual).  Long term effectiveness probably occurs because the attenuated microbe replicates in the body, increasing the original dose and acting as a secondary (booster) immunization.  Example: MMR (measles mumps and rubella) and TB  Risk: Weakened microbes can back-mutate to virulent form
  • 10. Types of Vaccines 2. Inactivated whole-agent vaccines  Use microbes that have been killed, usually by formalin or phenol.  Examples of viruses: rabies, influenza, and Salk polio.  Examples of bacteria: pneumococcal pneumonia and cholera. 3. Toxoids  Inactivated toxins  Tetanus and diphtheria
  • 11. Types of Vaccines 4. Subunit vaccines  Use only antigenic fragments of a microorganism that best stimulates the immune response.  Acellular: a vaccine consisting of antigenic parts (example- pertussis)  Recombinant: uses recombinant DNA technology; another microbes are programed to produce the antigenic parts (example-hepatitis B).
  • 12. Types of Vaccines 5. Conjugated Vaccine:  A vaccine consisting of the desired antigen and other proteins.  Deals with poor immune response of children to vaccines based on capsular polysaccharides (children typical to respond to these antigens until 18-24 months).  Polysaccharides are combined with proteins (diptheria toxoid) which gives significant protection (2 months).  Example: Haemophilus influenza type b
  • 13. Types of Vaccines 6. Nucleic acid (DNA) vaccines  Plasmid DNA injected into muscle results in the production of the protein antigen encoded on the DNA  Example: West Nile (for horses)  Clinical trials underway in humans  Many advantages for the less developed countries- gene gun eliminate needles and syringes, requires no refrigeration, and lower cost. ANIMATION Vaccines: Types
  • 14. Vaccines Used to Prevent Bacterial Diseases Disease Vaccine Diphtheria Purified diphtheria toxoid Meningococcal meningitis Purified polysaccharide from Neisseria meningitidis Pertussis (whooping cough) Killed whole or acellular fragments of Bordetella pertussis Pneumococcal pneumonia Purified polysaccharide from 7 strains of Streptococcus pneumoniae Tetanus Purified tetanus toxoid Haemophilus influenza type b meningitis Polysaccharide from Haemophilus influenzae type b conjugated with protein to enhance effectiveness
  • 15. Disease Vaccine Influenza Injected vaccine, inactivated virus (nasally administered: attenuated virus) Measles Attenuated virus Mumps Attenuated virus Rubella Attenuated virus Chickenpox Attenuated virus Poliomyelitis Killed virus Vaccines Used to Prevent Bacterial Diseases
  • 16. Disease Vaccine Rabies Killed virus Hepatitis B Antigenic fragments of virus Hepatitis A Inactivated virus Smallpox Live vaccinia virus Herpes zoster Attenuated virus Human papillomavirus Antigenic fragments of virus Vaccines Used to Prevent Bacterial Diseases
  • 17. Adults  Most adults don’t realize there are times when they, too, need vaccines:  At certain ages  During pregnancy  Before travel  For occupational risks  When they have certain medical conditions
  • 18. Vaccines for Adults • Td/Tdap • Human Papillomavirus (HPV) • Varicella • Herpes Zoster • Measles, Mumps and Rubella • Influenza • Pneumococcal • Hepatitis A • Hepatitis B • Meningococcus
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.
  • 24. Lecture prepared by Mark Randa; Ph.D. Herd Immunity
  • 26. Some of the population vaccinated…
  • 27. Most of the population vaccinated…
  • 28. R0: basic reproduction number; this number represents how many people in an unprotected population one infected person could pass the disease along to
  • 29.
  • 30. Lecture prepared by Mark Randa; Ph.D. Watch the Following Video (HAS PROFANITY) Penn & Teller's Bullshit – Vaccinations https://www.youtube.com/watch?v=lhk7-5eBCrs Anti-Vaccine Movement
  • 31. The cause of the anti-vaccine movement…  Many anti-vaccine parents mistakenly think that the scientific jury is out  In reality, there are no lingering questions, and it is important to recognize that deviousness was involved in the mere suggestion of a link.  Not only was there never any evidence to support the notion that the vaccination caused autism, the research that supposedly supported this link was in fact wholly fabricated.  Unfortunately, the facts of this fraud get forgotten.  Discussions occasionally mention that the research has been "discredited," but that description is in fact a massive understatement
  • 32. The journal article…  In 1998, a British surgeon, Dr. Andrew Wakefield, published a paper in The Lancet with 12 co-authors, reporting that the measles, mumps and rubella (MMR) vaccine was associated with "regressive autism" and colitis in 12 children.  The paper ignited and propelled anti-vaccine campaigns throughout the world.  A journalist, Brian Deer, began investigating these children's medical records and found that the paper's data were largely fabricated.
  • 33. The truth about the children…  Of the 11 children reported as having colitis, only 3 did, according to the medical records.  Wakefield claimed that all 12 children were "previously normal," while in fact 5 had developmental problems before receiving the vaccine.  Of the 9 with regressive autism, 3 had no autism at all.  Of the 8 children who reportedly developed symptoms only days after receiving the vaccine -- which would be important in convincing a court that the vaccine was to blame -- 6 took much longer, and for 2 it is not clear.  While Wakefield claimed 6 of the 12 children had all three features -- autism, colitis, and development of symptoms days after the vaccination, in fact, 0 did.
  • 34. And it gets worse…  It turns out that in 1994, a British-based anti-vaccine group, JABS, claimed that the MMR vaccine causes brain damage and other problems, and hired a lawyer, Richard Barr, who then retained Wakefield, a surgeon.  Barr began sending Wakefield patients from the group, and paid Wakefield over $700,000.  Most of the children's parents were associated with the anti- vaccine group -- hardly an unbiased group.
  • 35. What happened…  After Deer's investigation, Wakefield at first claimed innocence, saying that the other authors had written the final paper. In fact, he had written the paper, and the other authors had signed on.  The General Medical Council began an investigation, lasting 217 days, and concluded that Wakefield had falsified the research.  The Lancet later retracted the paper, but only 12 years after publishing it.
  • 36.
  • 37. Where is he now…  Wakefield's medical ambitions having been stifled, he is now appearing as a speaker at conspiracy crank events, as well as being the patron saint of anti-vaxxers everywhere.  In January 2012, Wakefield filed a defamation suit against Brian Deer, the British Medical Journal and the BMJ's editor Fiona Godlee personally.  The BMJ Group has noted that they stand by their article (and pointedly call him "Mr. Wakefield" throughout the press release to this effect). This suit was dismissed on jurisdictional grounds.